Vanguard Group Inc Statera Biopharma, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $0.28 $1,356 - $2,921	-10,433 Reduced 2.68%	378,677 $49,000
Q1 2022 May 13, 2022	SELL	$0.31 - $2.27 $8,757 - $64,125	-28,249 Reduced 6.77%	389,110 $122,000
Q4 2021 Feb 14, 2022	SELL	$2.01 - $4.08 $18,053 - $36,646	-8,982 Reduced 2.11%	417,359 $960,000
Q3 2021 Nov 12, 2021	BUY	$2.29 - $6.24 $976,320 - $2.66 Million	426,341 New	426,341 $984,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.